高级检索
当前位置: 首页 > 详情页

Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma: a single-center experience of 114 cases

| 认领 | 导出 |

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Department of Surgical Oncology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China [2]Depart­ment of Hepatobiliary Surgery, China-Japan Friendship Hospital, Beijing, China [3]Department of Abdominal Sur­gery, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China
出处:
ISSN:

关键词: Intrahepatic cholangiocarcinoma hepatectomy prognosis

摘要:
Objectives: Intrahepatic cholangiocarcinoma (ICC) remains a rare tumor, although its incidence is increasing. The surgical outcome and prognostic factors of ICC are not fully understood. This study aimed to examine surgical outcomes for patients and prognostic factors for survival in patients with ICC. Patients and methods: We retrospectively studied 114 patients with ICC who underwent hepatectomy from January 2001 to December 2012 at the Hepatobiliary Surgery Center, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China. Survival outcomes were analyzed using Cox hazard models and the Kaplan-Meier method. Results: Genarally, of the 114 patients, median age was 56.3 years, and 53.1% were male. Most patients (74.7%) had a solitary tumor, and median tumor size was 5.92 cm. Patients were treated with an extended hepatectomy, a hemihepatectomy (180 [35.0%]), or a minor liver resection. 87.9% of patients underwent R0 resection, and 35.7% of patients had N1 disease. For prognosis, using backward selection of clinically relevant variables, lymph node metastases (hazard ratio [HR]: 3.887; P = 0.033), vascular invasion (HR: 2.848; P = 0.046), multiple tumors (HR: 7.069; P = 0.001), elevated preoperative CA19-9 level (HR: 4.165; P = 0.006) were selected as factors predictive of survival. Conclusions: Predictive factors, including lymph node metastases, vascular invasion, multiple tumors, and an elevated preoperative CA19-9 level were associated with poor survival.

语种:
WOS:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验
JCR分区:
出版当年[2015]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2015版] 出版当年五年平均[2011-2015] 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者单位: [1]Department of Surgical Oncology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China
共同第一作者:
通讯作者:
通讯机构: [3]Department of Abdominal Sur­gery, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China [*1]Department of Abdominal Surgery, Cancer Hospital Chinese Academy of Medical Sciences, 17 Panjiayuannanli Road, Chaoyang District, Beijing 100021, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:817 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)